Diagnoses, prevalence, and state-based federal spending for HIV prevention and treatment in the United States, 2006–2009

Table 1 Correlations of state-based federal funding for HIV, HIV diagnosis rates, and HIV prevalence rates, 2006-2009 ¹

	2006				2007				2008				2009
	HIV diagnosis rate		HIV prevalence rate		HIV diagnosis rate		HIV prevalence rate		HIV diagnosis rate		HIV prevalence rate		HIV diagnosis rate		HIV prevalence rate
	r	r _s	r	r _s	r	r _s	r	r _s	r	r _s	r	r _s	r	r _s	r	r _s
Total state-based federal funding for HIV	.728	.902	.827	.902	.730	.895	.836	.899	.720	.843	.825	.834	.706	.895	.838	.908
State-based federal funding for HIV prevention	.700	.878	.826	.888	.698	.867	.835	.888	.696	.855	.832	.895	.664	.861	.823	.887
State-based federal funding for HIV treatment	.739	.915	.830	.911	.745	.901	.839	.902	.731	.817	.824	.797	.718	.908	.843	.915

¹Data limited to the 40 states with confidential name-based HIV infection reporting during the time horizon of the study.
r = Pearson’s correlation coefficient.
r_s = Spearman’s rank correlation coefficient.
All correlations significant at p < .01.

ISSN: 1742-6405